Leading global pharmaceutical major with distribution across multiple countries
The client’s marketing team was planning to launch a pilot campaign which involved replacing the in-person representative detailing by multichannel marketing (MCM) for a mid-cap drug in the diabetic market. The team wanted a sample set of prescribers to be exposed to this campaign so as to accurately measure the effectiveness of the campaign.
SGA’s data analytics team divided the target base into test/control group, and employed non-traditional marketing methods to reach out to the test group:
Covered 95% of prescribers to maximize the effectiveness of the campaign.
20% decline in the brand’s total prescriptions after replacing in-person marketing with MCM.